Tobam’s Edwards Lifesciences Corp Position
Does Tobam own Edwards Lifesciences Corp (EW)? Yes — 73.1K shares worth $6M (+1.52% of its 13F portfolio) as of Q1 2026, up from 67.1K shares the prior filed quarter.
Position Value
$6M
Q1 2026
Shares
73.1K
% of Portfolio
+1.52%
Quarters Held
22
currently held
Position History EW
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 73.1K | $6M | +1.52% |
| Q3 2025 | 67.1K | $5M | +1.89% |
| Q2 2025 | 44.9K | $4M | +1.37% |
| Q1 2025 | 43.7K | $3M | +1.35% |
| Q4 2024 | 59.3K | $4M | +1.34% |
| Q3 2024 | 75.6K | $5M | +0.91% |
| Q2 2024 | 2.6K | $245,000 | +0.04% |
| Q1 2024 | 4.2K | $400,000 | +0.04% |
| Q4 2023 | 3.1K | $235,000 | +0.02% |
| Q3 2023 | 4.3K | $298,000 | +0.02% |
| Q2 2023 | 4.8K | $458,000 | +0.03% |
| Q1 2023 | 6.4K | $526,000 | +0.03% |
| Q4 2022 | 5.7K | $426,000 | +0.03% |
| Q3 2022 | 2.7K | $226,000 | +0.02% |
| Q2 2022 | 3.1K | $293,000 | +0.02% |
| Q1 2022 | 2.2K | $263,000 | +0.01% |
| Q4 2021 | 2.1K | $274,000 | +0.01% |
| Q3 2021 | 2.1K | $240,000 | +0.01% |
| Q2 2021 | 2.1K | $219,000 | +0.01% |
| Q1 2021 | 2.1K | $177,000 | +0.01% |
| Q4 2020 | 2.1K | $193,000 | +0.01% |
| Q3 2020 | 2.1K | $169,000 | +0.01% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Tobam’s full portfolio or all institutional holders of EW.